We have previously shown that a majority of the TAMs in the primary tumor core are double positive for the CD68 and F4/80 markers, and the TAMs in the invading tumor front are both CD68 and F4/80 double-positive as well as F4/80-positive and CD68-negative TAMs [18]. The gene discussed is CD68; the disease is neoplasm.